These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8048391)

  • 1. Histopathologic changes following irradiation for uveal tract melanoma.
    Petrovich Z; McDonnell JM; Palmer D; Langholz BM; Liggett PE
    Am J Clin Oncol; 1994 Aug; 17(4):298-306. PubMed ID: 8048391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
    Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
    Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
    Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
    Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of primary and secondary enucleation for uveal melanoma.
    Pham CM; Custer PL; Couch SM
    Orbit; 2017 Dec; 36(6):422-427. PubMed ID: 28812919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Episcleral plaque radiotherapy for uveal melanoma.
    Giblin ME; Shields JA; Augsburger JJ; Brady LW
    Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.
    Messmer E; Bornfeld N; Foerster M; Schilling H; Wessing A
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):391-6. PubMed ID: 1505775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
    Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
    Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings.
    Shields CL; Shields JA; Karlsson U; Markoe AM; Brady LW
    Ophthalmology; 1989 Jun; 96(6):919-23; discussion 924. PubMed ID: 2740084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
    Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
    BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
    Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.
    Fili M; Lundell G; Lundell M; Seregard S
    Br J Ophthalmol; 2014 Oct; 98(10):1349-54. PubMed ID: 24825846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma.
    Luyten GP; Mooy CM; Eijkenboom WM; Stijnen T; Hellemons LP; Luider TM; de Jong PT
    Am J Ophthalmol; 1995 Jun; 119(6):786-91. PubMed ID: 7785695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
    Correa ZM; Huth B; Augsburger JJ
    Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
    Seregard S; Lundell G; Lax I; af Trampe E; Kock E
    Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pre-enucleation irradiation on the survival of patients with uveal melanoma.
    Günalp I; Batioğlu F
    Ophthalmologica; 1998; 212(4):231-5. PubMed ID: 9672210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.